Protein phosphorylation was examined in whole cell extracts from normal and avian sarcoma virus-transformed chicken embryo fibroblasts. The addition of serum or epidermal rowth factor to serum-starved normal cells resulted in increased P labeling of a Mr 30,000 protein. In extracts from cells transformed by a temperature-sensitive mutant of Schmidt-Ruppin virus, subgroup A, and grown at the permissive temperature, the protein was phosphorylated regardless of serum starvation. This Mr 30,000 protein was shown to be ribosomal protein S6, and the effects of avian sarcoma virus transformation on S6 phosphorylation were further investigated. The ability to phosphorylate S6 in the absence of serum was found to be temperature sensitive when S6 preparations from the temperature-sensitive mutant-infected cells incubated at permissive and nonpermissive temperatures were compared. Cells transformed by the parent virus (Schmidt-Ruppin, subgroup A) maintained the ability to phosphorylate S6 in the absence of serum when incubated at either temperature. Phosphoserine was the only phospho-amino acid detected in acid hydrolysates from phosphorylated S6 preparations
Recent investigations have emphasized the role ofprotein phosphorylation in growth regulation in normal cells and in the establishment and maintenance of the malignant state in virally transformed cells (1) (2) (3) . Mitogenic agents such as epidermal growth factor (4), insulin (5) , and insulin-like growth factor (6) have been shown to enhance phosphorylation ofcertain cellular proteins. In particular, all these growth-promoting peptides have been shown to stimulate the phosphorylation ofribosomal protein S6 when added to quiescent cell cultures (7) , and it has been suggested that phosphorylation of S6 may be required for the transition of serum-deprived cells into the G1 phase of the cell cycle (8) . S6 has been shown to be the primary poly(U) binding protein of the 40S ribosomal subunit (9) , and it has been postulated that phosphorylation of S6 alters the affinity of the ribosome for certain classes of mRNAs (7) . Most transformed cell lines show a reduced requirement for serum and are able to grow in the absence of at least one normally required growth factor (10) . If, indeed, growth factor-induced protein phosphorylation is important in the initiation of growth, these transformed cells have acquired the ability to perform such phosphorylation reactions independently of normally needed serum factors.
In this report, the phosphorylation state ofribosomal protein S6 has been determined in avian sarcoma virus (ASV)-infected cells under various conditions of serum deprivation.
MATERIALS AND METHODS
Cell Cultures. Subconfluent secondary cultures were used in all experiments involving chicken embryo fibroblasts. Pri-mary cultures were preparedfrom 10-to 11-day-old embryos as described by Vogt (11) . Secondary cultures were seeded in Scherer's maintenance medium/10% tryptose phosphate/5% calf serum containing beef embryo extract at 1.25-2.50 X 106 cells per 100-mm dish. ASV-transformed rat cell line RR 1022 (obtained from A. Goldberg, Rockefeller University) was seeded at 1 x 106 cells per dish in Dulbecco's modified Eagle's medium/10% calf serum. After 2 days incubation at 36°C, the cells were used for 32P-labeling experiments. Transformed chicken embryo fibroblasts were prepared by infecting primary cultures with the Schmidt-Ruppin strain, subgroup A, of ASV (SR-A) or with a temperature-sensitive mutant derived from this strain (ts 68) (both viruses kindly provided by H. Hanafusa, Rockefeller University). NaDodSOJPolyacrylamide Electrophoresis of Whole Cell Lysates. Two-day-old subconfluent cultures were drained and washed twice with 5 ml of Scherer's medium lacking phosphate, calf serum, beef embryo extract, penicillin, streptomycin, and phenol red and then incubated in 5 ml per dish of the same medium containing 100-200 ,uCi ofcarrier-free 32P (1 Ci = 3.7
x 1010 becquerels; Amersham) per dish. After 6 hr, some samples received 5% calf serum or epidermal growth factor at 500 ng/ml (Collaborative Research, Waltham, MA) for 15 min. Cells were then washed twice with 5 ml ofTMK buffer (5 mM Tris-HCV10 mM MgCJ2/80 mM KCI, pH 7.4) and lysed with 0.3 ml of 2% NaDodSOJ10% sucrose/5% mercaptoethanol. Lysates were heated at 100°C for-5 min and run on 5-16% NaDodSO4/polyacrylamide gels as described by Laemmli (12) .
Preparation of Ribosomal Pellets and Polyacrylamide Gel
Electrophoresis of Ribosomal Proteins. Ribosomes were prepared by a modification of the method of Haselbacher et al (6) . Cells were grown and labeled with 32P as described above. After the 6-hr labeling period, the monolayers were washed twice with 5 ml of TMK buffer and lysed with 2 ml per dish of cold TMK buffer/1% sodium deoxycholate/1% Triton X-100/10 mM KH2POd2 mM p aminobenzamidine dihydrochloride/2 mM l-p-bromotetramisole oxalate, pH 7.4. Extracts were centrifuged at 30,000 x g for 10 min, and the supernatants were layered over a cushion of 1.5 M sucrose in TMK buffer and spun at 100,000 x g for 2 hr. Pellets were washed and resuspended in TMK buffer. RNA was precipitated with 100 mM MgCl2/ 67% acetic acid, andithe precipitate was removed by centrifugation at 10,000 X g for 10 min. The supernatant was precipitated with 5 vol of cold acetone. Two-dimensional gel electrophoresis was performed using the method of Ramjoue and Gordon (13) , except that the first dimension was run on 1-mmthick slab gels (200 ,g of protein.per track) at 10 mA for 1 hr and 55 mA.for 16 hr rather than in tubes. The first-dimension Abbreviations:-ASV, avian sarcoma virus; SR-A, Schmidt-Ruppin strain; subgroupA ofASV, ts 68, temperature-sensitive mutant derived fiom SR-A.
The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. gel was dried and exposed, and tracks were cut out for the second-dimension gels, which were run at 10 mA for 1 hr and 50 mA for 8-10 hr. For direct quantification of 32P incorporation, labeled bands were cut from the first-dimension gels and assayed in Hydrofluor (National Diagnostics) in a Packard Tri-Carb liquid scintillation counter.
Phospho-Amino Acid Analysis. Identification of phosphorylated amino acids from partially hydrolyzed protein was done by one-dimensional high-voltage electrophoresis as described by Hunter and Sefton (14) . 32P-Labeled S6 protein bands cut from dried first-dimension urea gels were washed and rehydrated in 50 mM NaHCOJ0. 1% NaDodSO4. Gel bands were crushed with a glass pestle and shaken for 18 hr at 370C. The polyacrylamide fragments were removed by centrifugation, 100 ,Ag of ovalbumin was added to the eluted protein in the supernatant, and protein was precipitated with 20% cold trichloroacetic acid. The pellet was washed with ethanol at -100C, then with ice-cold ethanol/ether (1:1), dried, and dissolved in 6 M HCL. This solution was placed in a tube, which was sealed at reduced pressure, and heated at 1100C for 2 hr. The hydrolysate was lyophilized and subjected to high-voltage electrophoresis at pH 3.5 in glacial acetic acid/pyridine/H20, 50:5:945 (vol! vol).
Miscellaneous Measurements. ATP was measured by using a luciferin-luciferase assay (15) , and protein was determined by using either the method of Lowry et al. (16) or that of Bradford (17) .
RESULTS
32P-Labeling in Whole Cells. The banding patterns of the 32P-labeled macromolecules in whole cell lysates of 32P-labeled cells are shown in Fig. 1 . Serum-starved subconfluent normal cells display similar labeling compared with identically treated cells that had been incubated with 5% calf serum for 15 min before NaDodSO4 solubilization. The only obvious difference is the presence ofa heavily labeled Mr 30,000 band in the serumtreated cells. The same experiment was performed using ts 68infected cells incubated at the permissive temperature (36°C). With these cells, phosphorylation of the Mr 30,000 band was found to be independent of serum addition; similar heavy labeling occurred in the presence or absence of serum. Presumably, this Mr 30,000 band represented a phosphorylated protein because it was insensitive to ribonuclease treatment and sensitive to protease. Identification of the Mr 30,000 Protein. It has previously been shown that serum and certain growth factors and hormones enhance the phosphorylation of ribosomal protein S6, a protein that has an estimated Mr of 28,000-34,000 (7) . Ribosomes from in vivo 32P-labeled normal and ASV-infected cells were partially purified, and phosphorylation of basic ribosomal proteins was examined by using two-dimensional urea gel electrophoresis. The S6 protein in these preparations was identified by comparison ofthe Coomassie blue staining patterns with gel patterns described previously (8) , in particular, by substantiating the decrease in mobility toward the cathode as the protein is progressively phosphorylated [S6 exists in at least five phosphorylation states (8) ]. As shown in Fig. 2 , the S6 protein from serum-starved normal cells was predominantly in the less phosphorylated cathodal position and lined up diagonally with proteins S2 and S4. However, when serum was added, the position of the S6 protein shifted toward the anode such that the predominantly stained portion was to the anodal side ofprotein S4 (Fig. 2C ). In the autoradiograms from these gels, very little label was incorporated into the heavily stained spot from serumstarved cells while the major spot from serum incubated cells was strongly labeled. These observations are largely in agreement with those ofHaselbacher et al. (6) . Gels ofbasic ribosomal proteins from ts 68-infected cells are shown in Figs. 3 and 4 . When the cells were serum-starved at the permissive temperature (36°C), S6 was located in the heavily phosphorylated anodal position, regardless of the presence or absence of serum (Fig. 3) . In contrast, when cells were 32P-labeled at the nonpermissive temperature (42°C) in the absence of serum, S6 phosphorylation was minimal ( Fig. 4) , with the Coomassie blue staining spot positioned as in serum-starved normal cells. Addition of serum to these cells stimulated phosphorylation of S6 and caused the anodal shift to occur (Fig. 4C ). When similar experiments were done using cells transformed by the wild-type virus ( and ATP levels were unaffected by the temperature shift. Phospho-amino acid analyses of acid hydrolysates of the S6 bands showed that phosphoserine was the only phospho-amino acid detected. An autoradiogram of S6 hydrolysate from 32P-labeled ts 68-transformed cells is shown in Fig. 5 .
The results of attempts to quantitate the relative extent of phosphorylation ofprotein S6 from different cultures are shown in Table 1 . They support the general trends suggested by the degree of anodal shift seen in stained gels, with an =6-fold increase in 32p in serum-stimulated normal cells and in serumstimulated ts 68-infected cells grown at the nonpermissive temperature. Serum addition had little effect on 3 P incorporation in ts 68-transformed cells incubated at 36°C or in SR-A-transformed cells. In an ASV-transformed rat cell line (RR 1022), the level of phosphorylation of S6 was also unaffected by the presence or absence of serum. Addition of epidermal growth factor (500 ng/ml) to serum-starved normal cells caused an appreciable increase in phosphate incorporation, as well as an anodal shift in the Coomassie blue staining spot (not shown). This effect is somewhat unexpected, as chicken embryo fibroblasts bind only small amounts of epidermal growth factor (S. Cohen, personal communication) and is perhaps due to the relatively high concentration used in these experiments. At 500-1000 ng/ml, epidermal growth factor stimulates thymidine incorporation in our chicken embryo fibroblast cultures (not shown).
DISCUSSION
This report confirms the observation that serum stimulates the phosphorylation ofribosomal protein S6 in normal chicken embryo fibroblasts (6) . The change in mobility of the S6 protein on two-dimensional gels indicates that the phosphorylation occurs quantitatively and is not a consequence ofalterations in the specific activity of 32P-labeled ATP pools, which would lead to changes in the specific activity of S6-bound phosphate and to misinterpretation of data based strictly on 32P assays.
Since many transformed cells show reduced requirements for serum or growth factors (10) and, indeed, many seem able to synthesize their own transformation-specific growth factors (18) , it was of interest to determine the effects of removal of growth factors (i.e., serum starvation) on S6 phosphorylation in ASV-transformed cells. As shown, transformed cells acquired the capacity to phosphorylate S6 in the absence ofserum (under conditions such that the unphosphorylated form ofS6 was found in serum-starved normal cells). If indeed S6 phosphorylation functions in the translation of certain mRNAs involved in initiation of cell division (15) , the ability of ASV-transformed cells to circumvent a normal cellular control mechanism by phosphorylating S6 independently of serum addition could be a factor contributing to their altered growth characteristics.
In addition, the fact that the ability of ts 68-infected cells to phosphorylate S6 in the absence of serum is temperature sensitive suggests that a functional src gene product is somehow involved in maintaining S6 in its phosphorylated form. This means that the transformed state, rather than virus multiplication, must be directly correlated to the phosphorylation of S6.
However, the fact that the phosphorylation of S6 takes place at serine residues suggests that S6 phosphorylation is not due to direct action of the src gene product which phosphorylates tyrosine residues exclusively (14, 19, 20) . Thus, it appears that the elevated phosphorylation of S6 in ASV-infected cells is a result of a transformation-specific alteration of metabolism that is induced and maintained by the src gene product. I wish to thank Dr. Fritz Lipmann, in whose laboratory this work was performed, for his encouragement and support throughout the course ofthis study. I would also like to thank Eric Schaeffer for excellent technical assistance. This work was supported by Grants GM-13972 from the National Institutes ofHealth and BC-340 from the American Cancer Society to F. Lipmann.
